Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucine Vuitton

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Alimentary Pharmacology & Therapeutics|June 6, 2019
Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort studyAurelien Amiot, Melanie Serrero, Laurent Peyrin-Biroulet, et al.
Alimentary Pharmacology & Therapeutics|April 5, 2021
Determinants of IBD-related disability: a cross-sectional survey from the GETAIDJenny Tannoury, Maria Nachury, Carole Martins, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 15, 2020
Impact of Gastric Electrical Stimulation on Economic Burden of Refractory Vomiting: A French Nationwide Multicentre StudyGuillaume Gourcerol, Benoit Coffin, Bruno Bonaz, et al.
Gastroenterology|October 25, 2019
Gastric Electrical Stimulation Reduces Refractory Vomiting in a Randomized Crossover TrialPhilippe Ducrotte, Benoit Coffin, Bruno Bonaz, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 14, 2020
Patients' real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID groupMaria Nachury, Yoram Bouhnik, Melanie Serrero, et al.
Inflammatory Bowel Diseases|July 11, 2022
Comparative Acceptability of Therapeutic Maintenance Regimens in Patients With Inflammatory Bowel Disease: Results From the Nationwide ACCEPT2 StudyAnthony Buisson, Mélanie Serrero, Laurie Orsat, et al.
British Journal of Cancer|April 28, 2018
A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalised medicineMichael Herfs, Patrick Roncarati, Benjamin Koopmansch, et al.
Journal of Crohn'S & Colitis|May 7, 2019
Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort StudyBenedicte Caron, Laurent Peyrin-Biroulet, Benjamin Pariente, et al.
The American Journal of Gastroenterology|November 6, 2020
Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAIDConstance Chapuis-Biron, Julien Kirchgesner, Benjamin Pariente, et al.
Expert Review of Anti-Infective Therapy|November 8, 2016
A European survey of perendoscopic treatment of biliary complications in patients with alveolar echinococcosisSylvain Ambregna, Stéphane Koch, Michael C Sulz, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Alimentary Pharmacology & Therapeutics|June 6, 2019
Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort studyAurelien Amiot, Melanie Serrero, Laurent Peyrin-Biroulet, et al.
Alimentary Pharmacology & Therapeutics|April 5, 2021
Determinants of IBD-related disability: a cross-sectional survey from the GETAIDJenny Tannoury, Maria Nachury, Carole Martins, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 15, 2020
Impact of Gastric Electrical Stimulation on Economic Burden of Refractory Vomiting: A French Nationwide Multicentre StudyGuillaume Gourcerol, Benoit Coffin, Bruno Bonaz, et al.
Gastroenterology|October 25, 2019
Gastric Electrical Stimulation Reduces Refractory Vomiting in a Randomized Crossover TrialPhilippe Ducrotte, Benoit Coffin, Bruno Bonaz, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 14, 2020
Patients' real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID groupMaria Nachury, Yoram Bouhnik, Melanie Serrero, et al.
Inflammatory Bowel Diseases|July 11, 2022
Comparative Acceptability of Therapeutic Maintenance Regimens in Patients With Inflammatory Bowel Disease: Results From the Nationwide ACCEPT2 StudyAnthony Buisson, Mélanie Serrero, Laurie Orsat, et al.
British Journal of Cancer|April 28, 2018
A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalised medicineMichael Herfs, Patrick Roncarati, Benjamin Koopmansch, et al.
Journal of Crohn'S & Colitis|May 7, 2019
Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort StudyBenedicte Caron, Laurent Peyrin-Biroulet, Benjamin Pariente, et al.
The American Journal of Gastroenterology|November 6, 2020
Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAIDConstance Chapuis-Biron, Julien Kirchgesner, Benjamin Pariente, et al.
Expert Review of Anti-Infective Therapy|November 8, 2016
A European survey of perendoscopic treatment of biliary complications in patients with alveolar echinococcosisSylvain Ambregna, Stéphane Koch, Michael C Sulz, et al.
Pageof 12